Ceftizoxime is a third-generation cephalosporin antibiotic administered parenterally to treat severe bacterial infections, including those caused by beta-lactamase-producing organisms. Its mechanism involves… Read more







Ceftizoxime is a third-generation cephalosporin antibiotic administered parenterally to treat severe bacterial infections, including those caused by beta-lactamase-producing organisms. Its mechanism involves inhibiting bacterial cell wall synthesis by binding to essential penicillin-binding proteins. Laboratories utilize the reference standards in this category, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to ensure rigorous quality control. These materials are essential for accurate impurity profiling, method validation, and routine analytical testing of the active pharmaceutical ingredient. By providing consistent standards for these related substances, chemists can identify degradation products and process-related impurities, supporting comprehensive regulatory compliance and efficacy testing in pharmaceutical manufacturing environments.